SIDRANSKY DAVID
Insider CIK 1277161 · ADXS Director · EPCTD Director · ORGS Director · AYLA Director · KVA Director · ACEL Director · CSBR Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2025-11-05 | 2025-11-07 | 21,216 | $6.80 | $144.3K | 21,216 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2024-11-12 | 2024-11-18 | 21,880 | $4.64 | $101.5K | 21,880 | SEC↗ |
| ORGS Orgenesis Inc. | A Award deriv | 2023-12-20 | 2023-12-21 | 20,450 | — | $0 | 20,450 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2023-11-03 | 2023-11-07 | 15,495 | $5.51 | $85.4K | 15,495 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 2,342 | — | $0 | 2,342 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 2,342 | — | $0 | 2,342 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 12,500 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 12,500 | — | $0 | 0 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award | 2023-01-19 | 2023-01-23 | 46 | — | $0 | 46 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer | 2023-01-19 | 2023-01-23 | 250 | — | $0 | 0 | SEC↗ |
| ORGS Orgenesis Inc. | A Award deriv | 2022-12-23 | 2022-12-29 | 20,450 | — | $0 | 20,450 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2022-11-01 | 2023-08-17 | 11,480 | $7.00 | $80.4K | 11,480 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | M Exercise deriv | 2022-10-12 | 2022-10-14 | 8,333 | — | $0 | 0 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | F Tax w/h | 2022-10-12 | 2022-10-14 | 3,562 | $7.51 | $26.8K | 767,043 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | M Exercise | 2022-10-12 | 2022-10-14 | 8,333 | $3.21 | $26.7K | 770,605 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2022-06-13 | 2022-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2021-11-05 | 2021-11-09 | 8,045 | $10.10 | $81.3K | 8,045 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2021-10-15 | 2021-10-19 | 16,667 | — | $0 | 0 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | F Tax w/h | 2021-10-15 | 2021-10-19 | 2,629 | $10.08 | $26.5K | 762,272 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | M Exercise | 2021-10-15 | 2021-10-19 | 16,667 | $1.59 | $26.5K | 764,901 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2021-06-10 | 2021-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | P Buy | 2020-12-23 | 2021-03-08 | 4 | $11.56 | $46 | 250 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2020-12-08 | 2020-12-10 | 8,333 | $11.96 | $99.7K | 8,333 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | M Exercise deriv | 2020-10-16 | 2020-10-28 | 16,667 | — | $0 | 0 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | F Tax w/h | 2020-10-16 | 2020-10-28 | 10,100 | $9.01 | $91.0K | 748,234 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | M Exercise | 2020-10-16 | 2020-10-28 | 16,667 | $5.46 | $91.0K | 758,334 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | P Buy | 2020-09-14 | 2021-03-08 | 1 | $10.70 | $11 | 246 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | P Buy | 2020-09-11 | 2021-03-08 | 10 | $10.07 | $101 | 245 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | P Buy | 2020-08-14 | 2021-03-08 | 5 | $11.07 | $55 | 235 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | P Buy | 2020-07-17 | 2021-03-08 | 4 | $11.86 | $47 | 230 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | P Buy | 2020-07-07 | 2021-03-08 | 1 | $9.60 | $10 | 226 | SEC↗ |
| ORGS Orgenesis Inc. | P Buy | 2020-05-20 | 2021-01-11 | 10 | $6.98 | $70 | 180 | SEC↗ |
| ORGS Orgenesis Inc. | P Buy | 2020-05-13 | 2021-01-11 | 70 | $5.96 | $417 | 170 | SEC↗ |
| ORGS Orgenesis Inc. | P Buy | 2020-05-12 | 2021-01-11 | 90 | $5.90 | $531 | 100 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | P Buy | 2020-05-12 | 2021-03-08 | 25 | $15.02 | $376 | 225 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | P Buy | 2020-05-08 | 2021-03-08 | 200 | $15.27 | $3.1K | 200 | SEC↗ |
| ORGS Orgenesis Inc. | P Buy | 2020-05-07 | 2021-01-11 | 10 | $5.42 | $54 | 10 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2020-05-04 | 2020-05-05 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ORGS Orgenesis Inc. | A Award deriv | 2020-03-19 | 2020-03-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ORGS Orgenesis Inc. | A Award deriv | 2019-12-17 | 2020-01-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2019-11-04 | 2019-11-06 | 8,333 | $5.43 | $45.2K | 8,333 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2019-10-24 | 2019-10-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2018-11-05 | 2018-11-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2018-11-01 | 2018-11-05 | 8,333 | $12.73 | $106.1K | 8,333 | SEC↗ |
| ORGS Orgenesis Inc. | A Award deriv | 2018-10-22 | 2018-10-25 | 29,200 | — | $0 | 29,200 | SEC↗ |
| ORGS Orgenesis Inc. | A Award deriv | 2018-10-22 | 2018-11-05 | 29,200 | — | $0 | 29,200 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2018-06-26 | 2018-06-27 | 15,000 | — | $0 | 110,355 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2018-06-13 | 2018-06-14 | 5,000 | $1.71 | $8.6K | 95,355 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2018-06-12 | 2018-06-13 | 3,198 | $1.85 | $5.9K | 83,553 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2018-06-12 | 2018-06-13 | 6,802 | $1.84 | $12.5K | 90,355 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2017-11-02 | 2017-11-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ORGS Orgenesis Inc. | A Award deriv | 2016-12-09 | 2019-03-05 | 41,667 | — | $0 | 41,667 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2016-11-03 | 2016-11-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2016-11-01 | 2016-11-03 | 16,667 | — | $0 | 16,667 | SEC↗ |
| ADXS Advaxis, Inc. | S Sale | 2016-08-09 | 2016-08-10 | 11,404 | $14.85 | $169.3K | 80,355 | SEC↗ |
| ADXS Advaxis, Inc. | S Sale | 2016-08-08 | 2016-08-10 | 11,404 | $15.17 | $173.0K | 91,759 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2015-11-05 | 2015-11-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-11-05 | 2015-11-06 | 2,744 | — | $0 | 103,163 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2015-11-02 | 2015-11-04 | 16,667 | — | $0 | 16,667 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2015-03-30 | 2015-04-01 | 15,000 | — | $0 | 100,419 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | A Award deriv | 2015-01-08 | 2015-01-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | A Award | 2015-01-08 | 2015-01-12 | 3,409 | — | $0 | 21,699 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy deriv | 2014-11-26 | 2014-12-03 | 2,600 | — | $0 | 2,600 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy | 2014-11-26 | 2014-12-03 | 10,400 | $2.50 | $26.0K | 18,290 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-11-03 | 2015-02-04 | 25,115 | — | $0 | 85,419 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2014-10-13 | 2014-10-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2014-07-17 | 2014-07-18 | 50,000 | — | $0 | 60,304 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy deriv | 2014-06-23 | 2014-06-25 | 1,600 | — | $0 | 1,600 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy deriv | 2014-03-10 | 2014-03-12 | 40 | — | $0 | 40 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy deriv | 2014-03-10 | 2014-03-12 | 5,883 | — | $0 | 5,883 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | P Buy deriv | 2014-03-10 | 2014-03-12 | 5,883 | — | $0 | 5,883 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | A Award deriv | 2013-12-12 | 2013-12-26 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2013-11-18 | 2013-11-26 | 10,309 | $4.85 | $50.0K | 10,309 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | A Award deriv | 2013-10-10 | 2013-10-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IMNP IMMUNE PHARMACEUTICALS INC | A Award deriv | 2013-10-10 | 2013-10-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-20 | 7,500 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-20 | 10,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-20 | 20,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-20 | 20,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other | 2013-09-16 | 2013-09-20 | 1,000 | — | $0 | 0 | SEC↗ |
| EPCTD IMMUNE PHARMACEUTICALS INC | A Award deriv | 2013-08-25 | 2013-08-28 | 1,190 | — | $0 | 1,190 | SEC↗ |
| EPCTD IMMUNE PHARMACEUTICALS INC | A Award deriv | 2013-08-25 | 2013-08-28 | 29,758 | — | $0 | 29,758 | SEC↗ |
| EPCTD IMMUNE PHARMACEUTICALS INC | A Award | 2013-08-25 | 2013-08-28 | 5,951 | — | $0 | 5,951 | SEC↗ |
| ORGS Orgenesis Inc. | A Award deriv | 2013-07-16 | 2018-10-25 | 20,834 | — | $0 | 20,834 | SEC↗ |
| ACEL Tamir Biotechnology, Inc. | A Award deriv | 2012-07-23 | 2012-07-25 | 540,000 | — | $0 | 540,000 | SEC↗ |
| KVA KV PHARMACEUTICAL CO /DE/ | A Award deriv | 2012-05-14 | 2012-05-16 | 20,000 | — | $0 | 20,000 | SEC↗ |